GlycoConnect
- World
Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards
Amsterdam, Netherlands: Synaffix B.V., a biotechnology company enabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces that it has won…
Read More » - Business
Synaffix Sees Competitive Early In Vivo Data from ADCs Based on Proprietary Exatecan Linker-Payload
Amsterdam, Netherlands: In vivo efficacy on a par with gold standard deruxtecan-based ADCs Poster to be presented at World ADC…
Read More »